Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000677 |
Amsacrine |
WRN gene mutant form results in increased susceptibility to Amsacrine | increases response to substance | 10725663
|
D001554 |
Benzene |
WRN gene SNP results in increased susceptibility to Benzene | increases response to substance | 16728435
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of WRN mRNA | decreases expression | 19150397
|
C074702 |
chromium hexavalent ion |
chromium hexavalent ion affects the localization of WRN protein | affects localization | 19487340
|
C074702 |
chromium hexavalent ion |
WRN protein mutant form results in increased susceptibility to chromium hexavalent ion | increases response to substance | 19487340
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of WRN mRNA | increases expression | 20106945
|
D005047 |
Etoposide |
WRN gene mutant form results in increased susceptibility to Etoposide | increases response to substance | 10725663
|
C031927 |
hydroquinone |
WRN protein affects the reaction [hydroquinone results in increased acetylation of TP53 protein] | affects reaction|increases acetylation | 17875398
|
C031927 |
hydroquinone |
WRN protein affects the reaction [hydroquinone results in increased expression of H2AFX protein] | affects reaction|increases expression | 17875398
|
C031927 |
hydroquinone |
WRN protein affects the reaction [hydroquinone results in increased expression of TP53 protein] | affects reaction|increases expression | 17875398
|
C031927 |
hydroquinone |
WRN protein results in decreased susceptibility to hydroquinone | decreases response to substance | 17875398
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of WRN mRNA | affects binding|increases activity|increases expression | 19710929
|
C017947 |
sodium arsenite |
sodium arsenite results in increased expression of WRN protein | increases expression | 19072884
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.34 | 18653653 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
3.76 | 16434500 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
5.02 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
5.22 | 17306315 16712894 |
MESH:D000741 |
Anemia, Aplastic |
|
Benzene |
4.53 | 11369114 14761424 17661222 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
3.35 | 19483382 |
MESH:D001855 |
Bone Marrow Diseases |
|
Benzene |
5.55 | 16183116 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Etoposide |
5.48 | 14601052 |
MESH:D001943 |
Breast Neoplasms |
|
Benzene |
2.70 | 17162533 11921183 |
MESH:D001943 |
Breast Neoplasms |
|
Etoposide |
2.70 | 16322251 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
1.99 | 17306315 16507464 15276417 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
2.43 | 18572023 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
11.98 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
11.98 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
11.98 | 20056578 19524636 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
8.26 | 19486331 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
8.26 | 19176532 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Benzene |
2.45 | 15643154 |
MESH:D003872 |
Dermatitis |
|
Benzene |
5.02 | 15902427 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.51 | 18249437 |
MESH:D004487 |
Edema |
|
pirinixic acid |
2.68 | 12083418 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.11 | 20426865 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
8.25 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
8.25 | 20131406 19236843 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
3.40 | 12168785 12639820 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.96 | 16452187 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.50 | 8708960 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.65 | 20558911 |
MESH:D006402 |
Hematologic Diseases |
|
Benzene |
4.87 | 16183116 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.71 | 15720958 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
3.25 | 16221962 19176532 19772884 18467677 |
MESH:D006561 |
Herpes Simplex |
|
Amsacrine |
11.60 | 10809021 |
MESH:D006561 |
Herpes Simplex |
|
Etoposide |
11.60 | 10809021 |
MESH:D006689 |
Hodgkin Disease |
|
Etoposide |
8.26 | 17606976 18180244 16135485 16200630 15147373 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
8.26 | 12676792 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.38 | 20558911 |
MESH:D006973 |
Hypertension |
|
Benzene |
5.61 | 17940673 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
5.61 | 10903974 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
3.12 | 15346721 12646999 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.76 | 16306350 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.76 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
6.38 | 8314463 10903974 18776723 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
6.38 | 20008137 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
2.90 | 12371664 |
MESH:D007938 |
Leukemia |
|
Benzene |
3.48 | 14694614 18335105 15935818 17119257 |
MESH:D007951 |
Leukemia, Myeloid |
|
Benzene |
4.52 | 17506065 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Amsacrine |
4.88 | 15148258 18043129 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Benzene |
4.88 | 19478238 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
1.35 | 15474484 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
4.71 | 16377806 20007298 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
4.71 | 16712894 15276417 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Benzene |
3.41 | 12562636 |
MESH:D008171 |
Lung Diseases |
|
chromium hexavalent ion |
8.42 | 16775837 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
8.42 | 19095001 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Benzene |
5.13 | 14698565 |
MESH:D008175 |
Lung Neoplasms |
|
Benzene |
3.87 | 12562636 |
MESH:D008175 |
Lung Neoplasms |
|
chromium hexavalent ion |
3.87 | 16876463 16570259 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
3.87 | 17306315 19931552 17077188 16712894 15276417 |
MESH:D008223 |
Lymphoma |
|
Benzene |
8.49 | 17584886 17119257 |
MESH:D008223 |
Lymphoma |
|
Etoposide |
8.49 | 12854902 12556972 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Benzene |
4.73 | 12562636 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Benzene |
3.43 | 11921183 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
2.05 | 16487513 19082730 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.11 | 16801185 |
MESH:D009101 |
Multiple Myeloma |
|
Benzene |
3.80 | 17119195 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.76 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.21 | 19151258 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.10 | 16411023 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
5.25 | 17405874 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
5.25 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.92 | 20056578 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.76 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.47 | 19348381 18481113 |
MESH:D009436 |
Neural Tube Defects |
|
Benzene |
7.97 | 15643154 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
7.97 | 12854658 |
MESH:D009669 |
Nose Neoplasms |
|
chromium hexavalent ion |
5.40 | 16876463 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.85 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
Benzene |
4.37 | 17119257 15913788 15612468 15576619 15727169 17479406 16737584 15935809 17178637 |
MESH:D010051 |
Ovarian Neoplasms |
|
Benzene |
5.30 | 12562636 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
5.30 | 17306315 15276417 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Etoposide |
3.33 | 19003803 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.40 | 12371664 |
MESH:D011471 |
Prostatic Neoplasms |
|
Etoposide |
3.52 | 17172428 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
3.52 | 16039940 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.29 | 16882103 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.47 | 19058328 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Etoposide |
4.94 | 14601052 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
2.78 | 19524636 18572023 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.95 | 12854658 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzene |
2.42 | 12562636 |
MESH:D013953 |
Thymus Neoplasms |
|
Benzene |
5.24 | 10850423 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
2.57 | 11723127 16712894 16452187 17306315 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
3.96 | 11813266 |
MESH:D014594 |
Uterine Neoplasms |
|
Benzene |
4.57 | 12562636 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.30 | 1336536 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.71 | 17056641 |
MESH:D014898 |
Werner Syndrome |
marker/mechanism |
|
| |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.76 | 17120751 |